Biopharma foresees a ‘quantum advantage’: they could be right

Biopharma foresees a ‘quantum advantage’: they could be right

Companies are betting on the power of quantum computing to simulate molecular dynamics, solve drug design and even accelerate clinical studies.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2024-05, Vol.42 (5), p.690-692
1. Verfasser: Chandran, Anita
Format: Artikel
Sprache:eng
Schlagworte:
Agriculture
Bioinformatics
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Drug development
Drug Industry - economics
Humans
Life Sciences
Molecular dynamics
News
Pharmacology
Quantum computing
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Companies are betting on the power of quantum computing to simulate molecular dynamics, solve drug design and even accelerate clinical studies.
ISSN:1087-0156
1546-1696
1546-1696
DOI:10.1038/s41587-024-02251-x